Comparing of Long Bout and Short Bouts of Similar Volume of Walking in Obese on Weight Loss During a Weight Loss Program

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT02387827
• Date of registration: 09/03/2015
• Prospective Registration: No
• Primary sponsor: Novindiet Clinic
• Public title: Comparing of Long Bout and Short Bouts of Similar Volume of Walking in Obese on Weight Loss During a Weight Loss Program
• Date of first enrolment: February 2015
• Target sample size: 60
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02387827
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
• Phase: N/A

Countries of recruitment

Iran, Islamic Republic of

Key inclusion & exclusion criteria

Inclusion Criteria:

- Must have Body mass index (BMI) between 27-35 kg/ m².

- were sedentary (reported exercising <20 min/d for the previous 6 month) and healthy

- Must be able to have moderate exercise.

- Must be interested to have weight loss.

Exclusion Criteria:

- Participating in a research project involving weight loss or physical activity in the
previous six months.

- Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next
six months.

- Taking medication that could affect metabolism or change body weight.

- Report heart problems, chest pain, and cancer within the last five years.

- Smoking

- Menopause

- Diagnosis of any chronic disease such as fatty liver, cancer, chemo/radio therapy,
heart disease, immune compromised conditions, abnormal thyroid hormone level.



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Obesity

Overweight

Intervention(s)

Behavioral: Diet+ short term versus long -term physical activity

Primary Outcome(s)

Body mass index reduction [Time Frame: 24 weeks]

weight loss [Time Frame: 24 weeks]

Secondary Outcome(s)

waist circumference [Time Frame: 24 weeks]

lipid profiles [Time Frame: 24 weeks]

Insulin resistance (HOMA) [Time Frame: 24 weeks]

Fasting plasma glucose level [Time Frame: 24 weeks]

Secondary ID(s)

ND-104

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University of Nottingham

Tehran University of Medical Sciences